Additionally, the efficacy of PS in eradicating CSCs in esophageal squamous cell carcinoma (ESCC) has been linked to its modulation of the NF-κB signaling pathway, further underscoring its therapeutic potential [64]. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.